Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-309
Yohimbine Hydrochloride
Cat. No.
AKA-309
CAS No.
65-19-0
MF
C21H26N2O3.HCl
MW
390.90368
Yohimbine Hydrochloride is an α-2 adrenergic receptor inhibitor that blocks pre- or post-synaptic α-2 adrenergic receptors, causing the release of norepinephrine and dopamine.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com Technical Data
Description
Documents
Storage and Shipping
References
Product Name
Yohimbine Hydrochloride
CAS No.
65-19-0
MF
C21H26N2O3.HCl
MW
390.90368
Specification
98%
Research Area
Yohimbine hydrochloride is an α-2 adrenergic receptor antagonist, primarily investigated for the treatment of erectile dysfunction, and possesses additional effects such as local anesthesia and blood pressure elevation.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Description
Yohimbine Hydrochloride is an α-2 adrenergic receptor inhibitor that blocks pre- or post-synaptic α-2 adrenergic receptors, causing the release of norepinephrine and dopamine. Packing: 1kg/bag; 25kg/drum or as request Availability: In stock
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store sealed, protected from light, at 2-8°C.
References
[1]. Docherty JR. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat. European Journal of Pharmacology. 2012 Mar 15;679(1-3):90-4.
[2]. Damase-Michel C, et al. The effect of yohimbine on sympathetic responsiveness in essential hypertension. European Journal of Clinical Pharmacology. 1993;44(2):199-201.
[3]. Musso NR, et al. Yohimbine effects on blood pressure and plasma catecholamines in human hypertension. American Journal of Hypertension. 1995 Jun;8(6):565-71.
[4]. Sáiz J, et al. Yohimbine-induced alterations in alpha(2)-adrenoceptors in kidney regions of the spontaneously hypertensive rats: an autoradiographic analysis. Pharmacological Reports. 2008 May-Jun;60(3):391-8.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
